The latest price target for SHL Telemedicine (NASDAQ:SHLT) was reported by Litchfield Hills on March 14, 2024. The analyst firm set a price target for $11.00 expecting SHLT to rise to within 12 months (a possible 278.01% upside). 1 analyst firms have reported ratings in the last year.

The latest analyst rating for SHL Telemedicine (NASDAQ:SHLT) was provided by Litchfield Hills, and SHL Telemedicine initiated their buy rating.

There is no last upgrade for SHL Telemedicine

There is no last downgrade for SHL Telemedicine.

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of SHL Telemedicine, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for SHL Telemedicine was filed on March 14, 2024 so you should expect the next rating to be made available sometime around March 14, 2025.

While ratings are subjective and will change, the latest SHL Telemedicine (SHLT) rating was a initiated with a price target of $0.00 to $11.00. The current price SHL Telemedicine (SHLT) is trading at is $2.91, which is within the analyst’s predicted range.